NantHealth Inc represents a strong commitment to revolutionizing the healthcare industry through innovative technologies and solutions. The company's corporate philosophy revolves around improving patient outcomes by providing personalized and data-driven healthcare options. NantHealth Inc focuses on leveraging advanced analytics, real-time data, and artificial intelligence to empower healthcare professionals with actionable insights. The company strongly believes in fostering collaboration among different stakeholders within the healthcare ecosystem to drive meaningful change and optimize patient care. NantHealth Inc aims to deliver cutting-edge solutions that enable healthcare providers to deliver efficient, cost-effective, and high-quality care to patients, ultimately leading to better health outcomes.

NantHealth Inc is primarily present in the United States.

Some significant milestones achieved by NantHealth Inc include the successful completion of an IPO in 2016, securing partnerships with renowned healthcare providers and organizations, and the development and launch of innovative health technology solutions. The company has demonstrated remarkable progress in delivering advanced solutions that enable personalized and evidence-based medicine. Furthermore, NantHealth Inc's commitment to improving patient outcomes through the use of cutting-edge technology has garnered recognition and accolades within the industry. Prompted by their dedication to revolutionizing healthcare, NantHealth Inc has fostered numerous collaborations and achieved remarkable milestones in its pursuit of transforming medical practices.

NantHealth Inc. is a healthcare technology company established in 2010 by Dr. Patrick Soon-Shiong. With headquarters in California, it focuses on delivering innovative solutions to improve patient care and enhance clinical decision-making. NantHealth Inc. offers a wide range of personalized healthcare solutions, including advanced analytics, genomic sequencing, telehealth, and care coordination platforms. Leveraging cutting-edge technologies, the company aims to transform the healthcare industry by integrating data, diagnostics, and therapeutics. NantHealth Inc. has collaborated with leading healthcare organizations worldwide to provide comprehensive and precise healthcare solutions for patients. Through its innovative offerings, NantHealth Inc. strives to empower healthcare professionals and improve patient outcomes.

The main competitors of NantHealth Inc in the market include MedPace Holdings Inc, Cerner Corporation, and Koninklijke Philips N.V.

NantHealth Inc is primarily active in the healthcare industry.

The business model of NantHealth Inc. revolves around providing innovative healthcare solutions through the integration of technology, data, and medical expertise. NantHealth Inc. develops and delivers a diverse range of products and services, including advanced molecular and genomic analysis, cloud-based software platforms, and clinical decision support tools. By leveraging their unique capabilities, NantHealth Inc. aims to empower healthcare providers and patients with the tools necessary for personalized and precision medicine. With a focus on improving patient outcomes and streamlining healthcare delivery, NantHealth Inc. strives to shape the future of healthcare through innovative solutions.

Pašreizējais KGV NantHealth nevar tikt aprēķināts.

KUV šobrīd NantHealth nevar aprēķināt.

AlleAktien kvalitātes vērtējums NantHealth ir 4/10.

Pašreiz nevar aprēķināt apgrozījumu NantHealth.

Pašlaik peļņa NantHealth nevar tikt aprēķināta.

The company NantHealth Inc is a US-American company in the field of digital healthcare. It was founded in 2010 by Patrick Soon-Shiong, a successful entrepreneur in the biotechnology and oncology sector. NantHealth's business model is based on the development and marketing of IT solutions for the healthcare industry that help to improve the efficiency and quality of medical care. The company takes a holistic approach to healthcare and therefore offers various divisions. One of these divisions is the NantHealth Clinical Operating System (cOS), a platform for the digital networking of doctors, hospitals, and patients. This software is intended to optimize data exchange between the various actors in the healthcare sector, leading to better coordination of treatments and thus improved patient care. NantHealth also offers specialized solutions for cancer therapy. These include, among others, the GPS Cancer System, which is intended to enable precise diagnosis and treatment of cancer, as well as the Eviti Connect System, a platform for oncologists to access current study data and guidelines. Another offering from NantHealth is the home health solution called NaviNet. This is a platform that allows patients and their caregivers to communicate and coordinate the care process. This solution is particularly intended to help older and chronically ill patients stay in their familiar environment for longer while still receiving comprehensive medical care. NantHealth is also working on the development of artificial intelligence (AI) in healthcare. To this end, the company has founded NantAI, which is developing an AI platform for the analysis of images and clinical data. The goal is to enable faster and more accurate diagnosis as well as personalized therapy for patients. Overall, NantHealth's offerings aim to make healthcare more effective and efficient. Through the digitization and networking of the various actors in the healthcare sector, information should be made more quickly and easily accessible, which can lead to better diagnoses and treatments. The personalization of medical care also plays a major role in order to better consider individual needs and medical conditions. Overall, NantHealth is an innovative company that is at the forefront of the digital revolution in healthcare. With its diverse offerings and partnerships with other companies in the industry, NantHealth is committed to comprehensive digitization of the healthcare sector and thus contributes to the improvement of medical care.

NantHealth izmaksā dividendes 0 USD, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt NantHealth vai uzņēmums nedod dividendes.

NantHealth ISIN ir US6301041074.

NantHealth WKN ir A2ALP8.

NantHealth simbols ir NH.

Pēdējo 12 mēnešu laikā NantHealth maksāja dividendes apmērā. Tas atbilst aptuveni dividendes ražībai. Nākamajos 12 mēnešos NantHealth plāno maksāt dividendes 0 USD apmērā.

NantHealth pašreizējā dividendu rentabilitāte ir .

NantHealth maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos .

NantHealth pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0 USD. Tas atbilst dividendes ražībai 0 %.

NantHealth tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu NantHealth apmērā 0 USD, kas tika izmaksāta 21.08.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 21.08.2024..

Pēdējās dividendes izmaksa notika 21.08.2024..

Gadā 2023, NantHealth izmaksāja 0 USD dividendes.

NantHealth dividendes tiek izmaksātas USD.